Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases

Published:2019-10-14 Issue:8 Volume:120 Page:1420-1426
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Serrano Pablo E.¹²^ORCID,Gu Chu‐Shu²³,Husien Mohamed⁴,Jalink Diederick⁵,Ritter Anne⁵,Martel Guillaume⁶,Tsang Melanie E.⁷,Law Calvin H.⁸,Hallet Julie⁸^ORCID,McAlister Vivian⁹,Sela Nathalie⁹,Solomon Hannah¹⁰,Moulton Carol‐Anne¹⁰,Gallinger Steven¹⁰,Levine Mark²³

Affiliation:

1. Department of SurgeryMcMaster University Hamilton Ontario Canada

2. Ontario Clinical Oncology GroupMcMaster University Hamilton Ontario Canada

3. Department of OncologyMcMaster University Hamilton Ontario Canada

4. Grand River Regional Cancer Centre Kitchener Ontario Canada

5. Cancer Centre of Southeastern Ontario at Kingston General Hospital Kingston Ontario Canada

6. The Ottawa Hospital Ottawa Ontario Canada

7. St. Joseph's Health Centre Toronto Ontario Canada

8. Odette Cancer CentreSunnybrook Health Sciences Centre Toronto Ontario Canada

9. London Health Sciences Centre London Ontario Canada

10. University Health Network Toronto Ontario Canada

Funder

Ontario Ministry of Health and Long-Term Care

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.25735

Reference21 articles.

1. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

2. Survival after hepatic resection of colorectal cancer metastases

3. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

4. Repeat Hepatectomy for Colorectal Liver Metastases

5. Liver Resection for Colorectal Metastases

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resection of colorectal carcinoma liver metastases: A population-based study in outcomes and factors associated with recurrent disease;Current Problems in Diagnostic Radiology;2024-07

2. ctDNA-guided adjuvant treatment after radical-intent treatment of metastatic spread from colorectal cancer—the first interim results from the OPTIMISE study;Acta Oncologica;2023-09-22

3. Laparoscopic Hepatectomy for Hepatocellular Carcinoma;Highlights in Science, Engineering and Technology;2023-02-15

4. Synchronous Colorectal Liver Metastases considering Infectious Complications: Simultaneous or Delayed Surgery?;Evidence-Based Complementary and Alternative Medicine;2022-10-11

5. Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: A multicentre retrospective propensity score matching study;International Journal of Surgery;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3